S.4629

Amends telehealth law to allow clinical discretion in scheduling follow-up appointments for Schedule II drug prescriptions.

This bill amends the telehealth and telemedicine law to allow physicians and adult patients to have clinical discretion in scheduling follow-up appointments for the prescription of Schedule II substances. After an initial in-person examination, the physician and the patient can collaboratively establish a timeline for follow-up appointments, which can be conducted either in-person or remotely. The bill also removes references to the term "controlled dangerous substances," as the sponsor believes the word "dangerous" has overly negative connotations.